T-COVRIX Trademark

Trademark Overview

On Monday, June 7, 2021, a trademark application was filed for T-COVRIX with the United States Patent and Trademark Office. The USPTO has given the T-COVRIX trademark a serial number of 90758328. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, January 22, 2025. This trademark is owned by ImmunityBio, Inc.. The T-COVRIX trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations; biological preparations; pharmaceutical preparations; immune boosters being medicinal, biological and pharmaceutical preparations; all of the aforementioned for administration as a vaccine and for use in the treatment and/or prevention of cancer and infectious diseases, including coronavirus
t-covrix

General Information

Serial Number90758328
Word MarkT-COVRIX
Filing DateMonday, June 7, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, January 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements

Goods and ServicesMedicinal preparations; biological preparations; pharmaceutical preparations; immune boosters being medicinal, biological and pharmaceutical preparations; all of the aforementioned for administration as a vaccine and for use in the treatment and/or prevention of cancer and infectious diseases, including coronavirus

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunityBio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, June 10, 2021NEW APPLICATION ENTERED
Friday, August 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, January 16, 2022ASSIGNED TO EXAMINER
Monday, January 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 24, 2022NON-FINAL ACTION WRITTEN
Monday, January 24, 2022NON-FINAL ACTION E-MAILED
Monday, July 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 5, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 5, 2023SOU EXTENSION 1 FILED
Wednesday, April 5, 2023SOU EXTENSION 1 GRANTED
Friday, April 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 9, 2024SOU EXTENSION 3 GRANTED
Thursday, May 9, 2024SOU EXTENSION 3 FILED
Thursday, May 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 24, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 24, 2023SOU EXTENSION 2 FILED
Tuesday, October 24, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 13, 2024SOU EXTENSION 4 FILED
Wednesday, November 13, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 30, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 22, 2025SOU EXTENSION 4 GRANTED
Thursday, January 23, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

covrix preparations medicinal pharmaceutical biological infectious cancer coronavirus prevention including diseases